In a report released on January 27, Jessica Fye from J.P. Morgan maintained a Buy rating on Intra-Cellular Therapies (ITCI – Research Report), ...

J.P. Morgan analyst Michael Mueller maintained a Buy rating on Prologis (PLD – Research Report) on January 24 and set a price target of ...

Exelixis Inc (EXEL) stock saw a modest uptick, ending the day at $32.73 which represents a slight increase of $0.35 or 1.08% from the prior close of $32.38. The stock opened at $32.92 and touched a ...

Tech stocks suffered on "worries that Beijing is becoming increasingly competitive in the high-stakes artificial intelligence ...

Venture Global, Inc. ("Venture Global") announced today the pricing of its initial public offering of 70,000,000 shares of its Class A common stock, par value $0.01 ("Class A common stock") at a ...

RBC Capital Markets adjusted its outlook on Travelers Companies Inc. (NYSE:TRV) shares, reducing the price target to $268 from $273, while maintaining a Sector Perform rating. The $54.8 billion ...

In a recent filing with the Securities and Exchange Commission, J.P. Morgan Chase Commercial Mortgage Securities Trust 2012-C6 announced a change in its special servicer. Effective today, Midland Loan ...

NEW YORK, Jan. 27, 2025 /PRNewswire/ -- J.P. Morgan Asset Management today released ... Jed Laskowitz, Global Head of Private Markets and Customized Solutions: "Our 2025 Alternatives Outlook ...

NextEra Energy (NYSE:NEE – Get Free Report) had its target price upped by research analysts at BMO Capital Markets from $82.00 to $84.00 in a research report issued to clients and investors on Monday.

IBM delivered better-than-expected fourth-quarter results and unveiled its big bets on artificial intelligence strategies and ...